Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
crizotinib alk tyrosine kinase receptor small molecule Successful target TTD , drugbank , DGIDB Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 5.03 approved inhibitor
crizotinib hepatocyte growth factor receptor small molecule NA drugbank , DGIDB Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.85 approved inhibitor
crizotinib proto-oncogene c-met NA Successful target TTD , DGIDB Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.85 approved unknown
crizotinib proto-oncogene c-met NA Successful target TTD , DGIDB Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.85 approved inhibitor
crizotinib proto-oncogene c-ros NA Successful target TTD , DGIDB Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.93 approved inhibitor
crizotinib proto-oncogene c-ros NA Successful target TTD , DGIDB Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.93 approved unknown
click here to return to the previous page